Reproductive Sciences Small Business SEP – EMS (11)
The EMS Small Business SEP [EMS (11)] SBIR/STTR standing SEP reviews applications in areas concerned with the emerging technologies and methodologies across all aspects of pregnancy, reproductive and developmental physiology; these new and improved technologies and methodologies involve utility of molecular, cellular biological and bioengineering tools utilizing micro and nanotechnology in various reproductive processes including assisted reproductive processes. In general EMNR S11 covers science range of CMIR, CSME, ICER and PN study sections and invokes mammalian models, model organisms and also clinical studies.
Review Dates
Topics
- Endocrinology and neuroendocrinology of male and female reproductive tract.
- Estrogen receptors and endocrine disruptors, toxicology and hormonal treatment.
- Assisted reproductive technologies (ART) and development of devices related to reproduction.
- Studies of sperm, oocyte and fertilization and male contraceptives.
- Disorders of pregnancy and their treatment and study of female contraceptives.
- Implantation and pharmacological interventions
- Pediatric endocrinology including pediatric neuroendocrinology related to growth, development and lactation.
Shared Interests and Overlaps
- Biology of Development and Aging IRG – BDABDA
- Oncology 1 - Basic Translational IRG – OBTOBT
- Oncology 2 - Translational Clinical IRG – OTCOTC
- Interdisciplinary Molecular Sciences and Training IRG – IMSTIMST
- Cardiovascular and Respiratory Sciences IRG – CVRSCVRS
There are shared interests between the small business panels in Endocrine and Metabolic Systems Review Branch (EMS) and Small Business: Clinical Care and Health Interventions (CCHI 10) in the study of disorders related to metabolic and reproductive systems (diabetes, reproductive aging and menopause, obstetrics, neonatology, etc.). Applications are reviewed in EMS if the aims focus on improved therapeutic strategies and bio-engineering approaches for monitoring and studying these disorders. Applications are reviewed in CCHI 10 if the aims involve use of the technology or device to influence health behavior and risk.
There are shared interests between the small business panels in the Endocrine and Metabolic Systems Review Branch (EMS) and Small Business: Health Services and Systems (HSS 10) in the study of disorders related to metabolic and reproductive systems (diabetes, reproductive aging and menopause, obstetrics, neonatology, etc.). Applications are reviewed in EMS if the aims focus on improved therapeutic strategies and bio-engineering approaches for monitoring and studying these disorders. Applications are reviewed in HSS 10 if the aims focus on implementation of the approach in clinical practice or for use in clinical decision support.
